AzTrials
AzTrials

Parkinson DiseaseNCT05439967

The Effects of Augmented and Virtual Reality Gait Training on Patients With Parkinson's Disease

A study testing Augmented and Virtual Reality Gait and balanceTraining and Conventional Training in people with Parkinson Disease, run by Gazi University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In Parkinson's Disease (PD) rehabilitation, the treadmill is used both in aerobic training and in gait training, as it provides more walking distance and can include body weight supported systems. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Parkinson Disease
What is being tested?
Augmented and Virtual Reality Gait and balanceTraining and Conventional Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2021to 1 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • being diagnosed with Parkinson's Disease by a specialist physician
  • being grade 1-3 on the Hoehn and Yahr Staging Scale
  • being 40 years or older; and
  • individuals agreed to be included in the study after adequate information was given about the study

Who cannot join

  • People who standardised Mini-Mental State Examination score < 24
  • Having any cardiovascular, vestibular, musculoskeletal, or additional neurological disease.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

    Ankara

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of The Effects of Augmented and Virtual Reality Gait Training on Balance and Walking in Patients With Parkinson's Disease

In Parkinson's Disease (PD) rehabilitation, the treadmill is used both in aerobic training and in gait training, as it provides more walking distance and can include body weight supported systems. It has been reported that the C-Mill VR+ device, which is a treadmill system with augmented and virtual reality (VR) technology, improves gait adaptation and reduces the risk of falling in individuals with early to mid-stage PD. Several publications augmented reality (AR) and VR applications in PD was focused on balance activities that do not include ambulation. In other studies in the literature, it was stated that further research are needed to better understand the effects of VR gait training on gait and balance in PD. It was also stated in these studies that the effects of VR gait training should be examined with more objective measurement methods. As a result, it is seen that there is a need for studies examining the effects of augmented and virtual reality trainings in PD with objective measurement methods. Therefore, our study aimed to examine the effects of AR and VR gait training on gait and balance in individuals with early to mid-stage PD.

Read the detailed description

Participants included in the study will randomly divide were randomly divided into 2 groups as intervention (IG, n=15) and control (CG, n=15). IG was given augmented and virtual reality gait training together with conventional training (CT). CG was given CT only. The training was applied 3 days per week for 6 weeks in both groups. All evaluations will be made by the same physiotherapist by meeting with participants face to face. Inclusion in the research will be on a voluntary basis. As outcome measures, motor symptoms, balance, balance confidence and gait analyses were performed before and after intervention.

Being tested
Augmented and Virtual Reality Gait and balanceTraining, Conventional Training
Keywords
Parkinson's Disease, Exercise, Virtual Reality, Balance, Gait
Medical subject headings
Parkinson Disease, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Augmented and Virtual Reality Gait and balanceTrainingOther

    C-Mill VR+ device used for training. The training was carried out 3 days a week for 6 weeks, with each exercise session lasting approximately 1.5 hours, accompanied by a physiotherapist. Training started with conventional exercises, continued with C-Mill VR+ training, and ended with stretching and relaxation exercises. The patients in the intervention group were applied the exercises with the same principles with conventional training, except the exercises performed in standing and walking. Patients performed 10 exercises in AR and VR gait training for 4 minutes and resting the individuals by sitting for 1 minute between exercises.

  • Conventional TrainingOther

    Conventional training was applied to the patients in the control group. Conventional training was planned taking into account the following goals: increasing mobility by improving the impaired kinesthetic sensation; improving axial rotation, coordination, flexibility of soft tissues, mobility in and out of bed; increasing body image perception by improving upright and proper posture; and improving balance and gait. The training was applied 3 days a week for 6 weeks, with each exercise session lasting 40-50 minutes, accompanied by a physiotherapist. Each of the exercises was done in 2 sets of 10 repetitions. In gait training, each exercise was performed for 4 minutes.

Study groups in NCT05439967
Study groupRoleWhat they receive
InterventionExperimentalNot described
Receives: Other: Augmented and Virtual Reality Gait and balanceTraining
Conventional TrainingActive comparatorNot described
Receives: Other: Conventional Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Unified Parkinson's Disease Rating Scale (UPDRS-III)-Baseline

    The severity of motor symptoms is evaluated with 13 items in UPDRS-III. Items are scored between 0 and 4; 0 = no impairment, 4 = severe impairment. Higher scores indicate more serious impairment

    Measured: Assessment will be conducted before intervention

  2. Unified Parkinson's Disease Rating Scale (UPDRS-III)-Post Intervention

    The severity of motor symptoms is evaluated with 13 items in UPDRS-III. Items are scored between 0 and 4; 0 = no impairment, 4 = severe impairment. Higher scores indicate more serious impairment

    Measured: Assessment will be conducted immediately after the intervention

  3. Hoehn and Yahr Staging Scale -Baseline

    H\&Y defines individuals with PD in 5 different clinical stages according to their functional disability status and clinical findings. As the stage of H\&Y increases, the functional disability status of patients also increases

    Measured: Assessment will be conducted before intervention

  4. Hoehn and Yahr Staging Scale -Post Intervention

    H\&Y defines individuals with PD in 5 different clinical stages according to their functional disability status and clinical findings. As the stage of H\&Y increases, the functional disability status of patients also increases

    Measured: Assessment will be conducted immediately after the intervention

  5. Huber 360° Evolution System-baseline

    Static and dynamic standing balance was evaluated with the Huber 360° Evolution System(LPG Systems, Valence, France), which objectively evaluated postural sway and limits of stability. Stability test and stability limit test were performed with the system. The stability test was performed by recording the amount of sway of the center of pressure (CoP) under standing on double-leg and standing on single-leg conditions. The test was performed under eyes open and eyes closed conditions. The lower values obtained as a result of the test means that the amount of sway is low and the postural stability is better. In the limits of stability test, while on standing and with fixed feet position patients are asked to shift their weight in a total of eight directions according to the trigonometric coordinate system. The high values obtained as a result of the test means that the amount of CoP sway is high and the stability limits of the patient is good.

    Measured: Assessment will be conducted before intervention

  6. Huber 360° Evolution System-Post Intervention

    Static and dynamic standing balance was evaluated with the Huber 360° Evolution System(LPG Systems, Valence, France), which objectively evaluated postural sway and limits of stability. Stability test and stability limit test were performed with the system. The stability test was performed by recording the amount of sway of the center of pressure (CoP) under standing on double-leg and standing on single-leg conditions. The test was performed under eyes open and eyes closed conditions. The lower values obtained as a result of the test means that the amount of sway is low and the postural stability is better. In the limits of stability test, while on standing and with fixed feet position patients are asked to shift their weight in a total of eight directions according to the trigonometric coordinate system. The high values obtained as a result of the test means that the amount of CoP sway is high and the stability limits of the patient is good.

    Measured: Assessment will be conducted immediately after the intervention

  7. Berg Balance Scale (BBS)-Baseline

    Functional balance was evaluated with BBS . It consists of 14 functional activities that evaluate the static and proactive balance, in which the individual is observed directly by the evaluator in terms of desired performance. Each item is scored between 0 (inability to perform the activity) and 4 (doing the activity completely independently) according to the performance of the individual to perform the desired functional activity according to the time and distance conditions of the test. BBS is scored between 0 and 56, and higher test scores mean that the individual's balance is better

    Measured: Assessment will be conducted before intervention

  8. Berg Balance Scale-Post Intervention

    Functional balance was evaluated with BBS . It consists of 14 functional activities that evaluate the static and proactive balance, in which the individual is observed directly by the evaluator in terms of desired performance. Each item is scored between 0 (inability to perform the activity) and 4 (doing the activity completely independently) according to the performance of the individual to perform the desired functional activity according to the time and distance conditions of the test. BBS is scored between 0 and 56, and higher test scores mean that the individual's balance is better

    Measured: Assessment will be conducted immediately after the intervention

  9. Activities-specific Balance Confidence Scale (ABC) -Baseline

    The level of confidence that an individual feels during activities of daily living related to balance was evaluated with ABC. With 16 questions asked directly to the individual by the evaluator, the level of confidence ranged from 0% (totally unsafe) to 100% (totally safe). The total score is determined by summing the values of 16 items and dividing by 16, which is the total number of question items. A total score between 0 and 49 indicates a low functional level, between 50 and 80 indicates a moderate functional level, and between 81 and 100 indicates a high functional level.

    Measured: Assessment will be conducted before intervention

  10. Activities-specific Balance Confidence Scale (ABC) -Post Intervention

    The level of confidence that an individual feels during activities of daily living related to balance was evaluated with ABC. With 16 questions asked directly to the individual by the evaluator, the level of confidence ranged from 0% (totally unsafe) to 100% (totally safe). The total score is determined by summing the values of 16 items and dividing by 16, which is the total number of question items. A total score between 0 and 49 indicates a low functional level, between 50 and 80 indicates a moderate functional level, and between 81 and 100 indicates a high functional level.

    Measured: Assessment will be conducted immediately after the intervention

  11. Spatio-temporal gait analysis -Baseline

    In the evaluation of spatio-temporal parameters of gait, patients were asked to walk on the platform of the C-Mill VR+ device for 3 minutes at the highest confident speed they felt safe. Right-left step lengths, stride length, and step width were recorded in meters from the spatial parameters, while the right-left stance phase duration, right-left swing phase duration and total double support phase duration were recorded in seconds for the evaluation of temporal parameters. Additionally, walking speed and distance were recorded during these analyses.

    Measured: Assessment will be conducted before intervention

  12. Spatio-temporal gait analysis -Post Intervention

    In the evaluation of spatio-temporal parameters of gait, patients were asked to walk on the platform of the C-Mill VR+ device for 3 minutes at the highest confident speed they felt safe. Right-left step lengths, stride length, and step width were recorded in meters from the spatial parameters, while the right-left stance phase duration, right-left swing phase duration and total double support phase duration were recorded in seconds for the evaluation of temporal parameters. Additionally, walking speed and distance were recorded during these analyses.

    Measured: Assessment will be conducted immediately after the intervention

  13. Timed Up and Go Test (TUG)- Baseline

    Functional mobility was assessed with TUG. The patient was asked to stand up from the chair with the "walk" command, walk 3 m, turn around and sit back on the chair. The test was carried out on a flat 3 meter surface. In addition, TUG has been shown to be highly reliable in PD.

    Measured: Assessment will be conducted before intervention

  14. Timed Up and Go Test (TUG)- Post Intervention

    Functional mobility was assessed with TUG. The patient was asked to stand up from the chair with the "walk" command, walk 3 m, turn around and sit back on the chair. The test was carried out on a flat 3 meter surface. In addition, TUG has been shown to be highly reliable in PD.

    Measured: Assessment will be conducted immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2022
  2. Study start1 Jul 2021
  3. Primary completion30 Oct 2021
  4. Study completion1 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05439967
Sponsor's protocol ID
1-PD C-Mill
Status last verified
Jun 2022
First submitted
27 Jun 2022
Last updated
5 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Augmented and Virtual Reality Gait and balanceTraining and Conventional Training in people with Parkinson Disease, run by Gazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Unified Parkinson's Disease Rating Scale (UPDRS-III)-Baseline (time frame: Assessment will be conducted before intervention). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in